1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Ye, J. Mayer, K.L. Mayer, M.R. Stone, M.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 40 7820 7831 10.1021/bi010252s 11425309 NMR solution structure and backbone dynamics of the CC chemokine eotaxin-3. 2001 10.2210/pdb1g2s/pdb pdb_00001g2s 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 8412.857 EOTAXIN-3 1 man polymer SMALL INDUCIBLE CYTOKINE A26, MACROPHAGE INFLAMMATORY PROTEIN 4-ALPHA no no TRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKWVQKYISLLKTPKQL TRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKWVQKYISLLKTPKQL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample EOTAXIN-3 9606 LUNG Homo sapiens 469008 Escherichia coli BL21(DE3) BL21(DE3) PLASMID PET28A+ database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-03-13 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name Solution Structure of Eotaxin-3, Ensemble of 20 structures RCSB Y RCSB 2000-10-20 REL REL 1 3D_15N-separated_NOESY HNHA 15N, 13C simultaneously edited NOESY 3D_13C-separated_NOESY 13C-edited HSQC 20 mM 5 ambient 303 K The structures are based on a total of 1250 restraints, 1157 are NOE-derived distance constraints, 69 dihedral angle restraints, 17 distance restraints from hydrogen bonds. distance geometry-simulated annealing protocol implemented in XPLOR minimized average structure 2 mM eotaxin-3,U-15N, 20mM sodium acetate (deteurated), 90% H2O, 10% D2O 90% H2O/10% D2O 2 mM eotaxin-3,U-15N, 13C, 20mM sodium acetate (deteurated), 90% H2O, 10% D2O 90% H2O/10% D2O 2 mM eotaxin-3,U-15N, 13C, 20mM sodium acetate (deteurated), 100% D2O 100% D2O 0.5 mM eotaxin-3,10% 13C-labeled, 20mM sodium acetate (deteurated), 100% D2O 100% D2O Brunger structure solution X-PLOR XPLOR98.1 msi industry data analysis Felix felix98 Varian collection VNMR VNMR6.1 Laskowski structure solution Procheck_nmr PROCHECK v.3 Laskowski refinement Procheck_nmr PROCHECK v.3 500 Varian UNITY THR 1 n 1 THR 1 A ARG 2 n 2 ARG 2 A GLY 3 n 3 GLY 3 A SER 4 n 4 SER 4 A ASP 5 n 5 ASP 5 A ILE 6 n 6 ILE 6 A SER 7 n 7 SER 7 A LYS 8 n 8 LYS 8 A THR 9 n 9 THR 9 A CYS 10 n 10 CYS 10 A CYS 11 n 11 CYS 11 A PHE 12 n 12 PHE 12 A GLN 13 n 13 GLN 13 A TYR 14 n 14 TYR 14 A SER 15 n 15 SER 15 A HIS 16 n 16 HIS 16 A LYS 17 n 17 LYS 17 A PRO 18 n 18 PRO 18 A LEU 19 n 19 LEU 19 A PRO 20 n 20 PRO 20 A TRP 21 n 21 TRP 21 A THR 22 n 22 THR 22 A TRP 23 n 23 TRP 23 A VAL 24 n 24 VAL 24 A ARG 25 n 25 ARG 25 A SER 26 n 26 SER 26 A TYR 27 n 27 TYR 27 A GLU 28 n 28 GLU 28 A PHE 29 n 29 PHE 29 A THR 30 n 30 THR 30 A SER 31 n 31 SER 31 A ASN 32 n 32 ASN 32 A SER 33 n 33 SER 33 A CYS 34 n 34 CYS 34 A SER 35 n 35 SER 35 A GLN 36 n 36 GLN 36 A ARG 37 n 37 ARG 37 A ALA 38 n 38 ALA 38 A VAL 39 n 39 VAL 39 A ILE 40 n 40 ILE 40 A PHE 41 n 41 PHE 41 A THR 42 n 42 THR 42 A THR 43 n 43 THR 43 A LYS 44 n 44 LYS 44 A ARG 45 n 45 ARG 45 A GLY 46 n 46 GLY 46 A LYS 47 n 47 LYS 47 A LYS 48 n 48 LYS 48 A VAL 49 n 49 VAL 49 A CYS 50 n 50 CYS 50 A THR 51 n 51 THR 51 A HIS 52 n 52 HIS 52 A PRO 53 n 53 PRO 53 A ARG 54 n 54 ARG 54 A LYS 55 n 55 LYS 55 A LYS 56 n 56 LYS 56 A TRP 57 n 57 TRP 57 A VAL 58 n 58 VAL 58 A GLN 59 n 59 GLN 59 A LYS 60 n 60 LYS 60 A TYR 61 n 61 TYR 61 A ILE 62 n 62 ILE 62 A SER 63 n 63 SER 63 A LEU 64 n 64 LEU 64 A LEU 65 n 65 LEU 65 A LYS 66 n 66 LYS 66 A THR 67 n 67 THR 67 A PRO 68 n 68 PRO 68 A LYS 69 n 69 LYS 69 A GLN 70 n 70 GLN 70 A LEU 71 n 71 LEU 71 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N GLU 28 A N GLU 28 A O ILE 40 A O ILE 40 A N PHE 41 A N PHE 41 A O VAL 49 A O VAL 49 1 A ARG 2 0.292 SIDE CHAIN 1 A ARG 25 0.246 SIDE CHAIN 1 A ARG 37 0.316 SIDE CHAIN 1 A ARG 45 0.220 SIDE CHAIN 1 A ARG 54 0.272 SIDE CHAIN 1 A ILE 6 -93.14 39.42 1 A SER 7 -95.84 41.24 1 A PHE 12 -160.11 -64.05 1 A HIS 16 -114.77 74.83 1 A ARG 25 -124.40 -61.33 1 A SER 26 -153.54 -153.46 1 A GLU 28 -177.38 137.86 1 A LYS 66 -174.39 141.84 1 A LYS 69 -115.89 52.90 minimized average SOLUTION STRUCTURE OF EOTAXIN-3 1 N N A PRO 20 A PRO 20 HELX_P A THR 22 A THR 22 5 1 3 A LYS 55 A LYS 55 HELX_P A LYS 66 A LYS 66 1 2 12 disulf 2.021 A CYS 10 A SG CYS 10 1_555 A CYS 34 A SG CYS 34 1_555 disulf 2.021 A CYS 11 A SG CYS 11 1_555 A CYS 50 A SG CYS 50 1_555 CYTOKINE beta-beta-beta-alpha helix, CYTOKINE CCL26_HUMAN UNP 1 1 Q9Y258 MMGLSLASAVLLASLLSLHLGTATRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKW VQKYISLLKTPKQL 24 94 1G2S 1 71 Q9Y258 A 1 1 71 3 anti-parallel anti-parallel A VAL 24 A VAL 24 A PHE 29 A PHE 29 A VAL 39 A VAL 39 A THR 43 A THR 43 A LYS 48 A LYS 48 A THR 51 A THR 51